Sfoglia per RIVISTA
BMC INFECTIOUS DISEASES
Collezione ASL Città di Torino
Items : 9
Intermediate dose enoxaparin in hospitalized patients with moderate-severe COVID-19: a pilot phase II single-arm study, INHIXACOVID19. in BMC infectious diseases / BMC Infect Dis. 2023 Oct 24;23(1):718. doi: 10.1186/s12879-023-08297-7.
2023
ASL Città di Torino
Cosmi B; Giannella M; Fornaro G; Cristini F; Patacca A; Castagna A; Mazzaferri F; Testa S; Pan A; Lupi M; Brambilla P; Montineri A; Frattima S; Bignami EG; Salvetti M; De Stefano G; Grandone E; Di Perri G; Rozzini R; Stella A; Romagnoli A; Drago F; Viale P;
Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens. in BMC infectious diseases
2023
AOU Alessandria
ASL Città di Torino
AOU Novara
Bonfanti P; Di Biagio A; Falasca K; Taramasso L; Menzaghi B; Molteni C; Masiello A; Saracino A; Bargiacchi O; De Socio GV; Squillace N; Madeddu G; Sarchi E; Orofino G; Cascio A; Celesia BM; Vichi F; Pellicanò GF; Cicalini S; Maggi P; Ricci ED;
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity? in BMC infectious diseases / BMC Infect Dis. 2022 Sep 23;22(1):745. doi: 10.1186/s12879-022-07739-y.
2022
AOU Alessandria
ASL Città di Torino
Falasca K; Calza L; Parisini A; Cenderello G; Gulminetti R; Valsecchi L; Celesia BM; Martinelli CV; Pellicanò G; Sarchi E; Vichi F; Cascio A; Madeddu G; Gamboni G; Guastavigna M; Taramasso L; Molteni C; Squillace N; Menzaghi B; De Socio GV; Maggi P; Orofino G; Ricci E; Di Biagio A; Bonfanti P;
Convalescent or standard plasma versus standard of care in the treatment of COVID-19 patients with respiratory impairment: short and long-term effects. A three-arm randomized controlled clinical trial. in BMC infectious diseases / BMC Infect Dis. 2022 Nov 22;22(1):879. doi: 10.1186/s12879-022-07716-5.
2022
ASL Asti
AO Cuneo
ASL Cuneo 1
ASL Città di Torino
ASL Torino 4
AOU San Luigi di Orbassano
ASL Torino 3
ASL VCO
ASL Vercelli
Libanore V; Blangetti I; Benedetti V; Scozzari G; Mitola B; Vitale F; Liccardi MM; Chinaglia A; Calcagno A; Bergamo D; Aldieri C; Converso M; Russo ML; Baldassano S; Canta F; Marletto FP; De Micheli AG; Mattei A; Maddalena L; Delios G; Milan M; Baffa A; Russo A; Tornello A; Nucci A; Raso S; Costa C; Pittaluga F; Avolio M; et alii...
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study. in BMC infectious diseases / BMC Infect Dis. 2019 Jun 25;19(1):555. doi: 10.1186/s12879-019-4184-z.
2019
ASL Città di Torino
Maggi P; Santoro CR; Nofri M; Ricci E; De Gennaro N; Bellacosa C; Schiaroli E; Orofino G; Menzaghi B; Di Biagio A; Squillace N; Francisci D; Vichi F; Molteni C; Bonfanti P; Gaeta GB; De Socio GV;
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA). in BMC infectious diseases / BMC Infect Dis. 2018 Jul 31;18(1):357. doi: 10.1186/s12879-018-3268-5.
2018
ASL Città di Torino
Taramasso L; Tatarelli P; Ricci E; Madeddu G; Menzaghi B; Squillace N; De Socio GV; Martinelli C; Gulminetti R; Maggi P; Orofino G; Vichi F; Di Biagio A; Bonfanti P;
A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data. in BMC infectious diseases / BMC Infect Dis. 2017 Sep 30;17(1):658. doi: 10.1186/s12879-017-2755-4.
2017
ASL Città di Torino
Capetti AF; Cossu MV; Orofino G; Sterrantino G; Cenderello G; De Socio GV; Cattelan AM; Soria A; Rusconi S; Riccardi N; Baldin GM; Niero FP; Barbarini G; Rizzardini G;
HIV treatment and care among Italian inmates: a one-month point survey. in BMC infectious diseases / BMC Infect Dis. 2015 Dec 10;15:562. doi: 10.1186/s12879-015-1301-5.
2015
ASL Città di Torino
Monarca R; Madeddu G; Ranieri R; Carbonara S; Leo G; Sardo M; Choroma F; Casari S; Marri D; Muredda AA; Nava FA; Babudieri S;
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis. in BMC infectious diseases / BMC Infect Dis. 2013 Dec 1;13:563. doi: 10.1186/1471-2334-13-563.
2013
ASL Città di Torino
De Rosa FG; Motta I; Audisio E; Frairia C; Busca A; Di Perri G; Marmont F;